Bio*One Capital
Boston Scientific leads round for VC-backed Amaranth Medical
Amaranth Medical, a medical device manufacturer backed by Singapore’s Bio*One Capital and Phillip Private Equity, has received a Series C round of funding from US-listed Boston Scientific.
Singapore's DCP leads $20m Series B for Amaranth Medical
DCP Management has led the $20 million Series B round of funding for Amaranth Medical, a medical device manufacturer. Existing investors Bio*One Capital, Charter Life Sciences and Phillip Capital, as well as new entrant Venstar Capital, also participated.
Singapore's Bio*One, Adams Street, others, invest US medical device company TriReme
TriReme Medical Inc., which develops catheters and stents for treating vascular disease, has raised $17 million in Series D financing led by new Singaporean investor Bio*One Capital, as well as return investors Three Arch Partners and global private equity...